WHO identified 17 priority pathogens for vaccine development in landmark global study

The World Health Organization (WHO) released a groundbreaking study identifying 17 priority pathogens for vaccine development. This initiative represents the first global effort to systematically evaluate pathogens based on regional disease burden, the threat of antimicrobial resistance, and socioeconomic impact. Published in eBioMedicine, the study provides a comprehensive framework to guide future vaccine research and development efforts. Highlighting global health priorities The list includes long-established targets for vaccine research, such as HIV, malaria, and tuberculosis (TB), diseases responsible for an estimated 2.5 million deaths annually. Additionally, the report underscores the growing urgency to address pathogens like Group A Streptococcus and Klebsiella pneumoniae, which pose significant public health risks due to rising antimicrobial resistance. These pathogens are recognized as priorities for disease control across all regions, emphasizing the critical need for innovative vaccine solutions. Addressing disease burden and reducing costs Dr. Kate O’Brien, Director of the WHO Department of Immunization, Vaccines, and Biologicals, highlighted the...